Skip to main content

Mucus Relief D

NDC 0363-8708 · Walgreen Company

Generic nameguaifenesin and pseudoephedrine hydrochloride
Dosage formTABLET, MULTILAYER, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN, PSEUDOEPHEDRINE HYDROCHLORIDE
Strength600; 60 mg/1; mg/1
Pharmacologic classAdrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
Marketing categoryANDA

Packages

0363-8708-68 — 2 BLISTER PACK in 1 CARTON (0363-8708-68) / 18 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0363-7440 — dextromethorphan hydrobromide and guaifenesin, 0363-7470 — Children Cough and Chest Congestion, 0363-7480 — Childrens Stuffy Nose and Cold, 0363-7504 — Guaifenesin, 0363-7550 — Cough and Chest Congestion, 0363-7754 — Dextromethorphan HBr, Guaifenesin, 0363-7760 — dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 0363-8004 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-8005 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-8031 — Dextromethorphan HBr, Guaifenesin, 0363-8996 — ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE, 0363-9013 — GUAIFENESIN and DEXTROMETHORPHAN HYDROBROMIDE, 0363-9016 — ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE, 0363-9017 — ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, and PHENYLEPHRINE HYDROCHLORIDE, 0363-9042 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-9057 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 0363-9569 — Guaifenesin, 0363-9930 — Guaifenesin and Pseudoephedrine Hydrochloride, 0363-9946 — Guaifenesin and Pseudoephedrine HCl, 0485-0206 — BROMPHENIRAMINE MALEATE and PSEUDOEPHEDRINE HYDROCHLORIDE, +1673 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels